ClinicalTrials.gg
CompletedNCT00757289Updated May 19, 2017

Platelet-rich-plasma Treating Tennis Elbow

An interventional study of PRP Injection and Corticosteroid Injection in Pain, sponsored by Zimmer Biomet. Completed at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-05-19.

Sponsored by Zimmer Biomet · Not applicable, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
106
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 106 studies in Pain with a site in Netherlands — 10 open to participants now, 13 under way, 1 of them phase 3. Pain · Netherlands.

Enrollment
36th of 86
106 · median 85
Started
2007
with 4 others
No phase
43 of 106
7 open now
Registered
18th of 106
by date

Among the 106 studies in Pain with a site in Netherlands, this one is the 36th largest by enrollment of the 86 interventional ones that give a count, is one of 5 that started in 2007, is one of 43 with no phase, and was the 18th registered.

Pain

10,069 studies on the registry are indexed under Pain; 1,650 are open to participants now.

Browse Pain studies →

Open to participants now

10 of the 106 studies in Pain with a site in Netherlands are open now. Recruiting first, the newest first:

5 more — sign in →

All 10 open studies →

A study can be open while its sites in Netherlands have not opened yet or have stopped. Only those recruiting at a site in Netherlands →

Who these studies take

Of the 927 Pain studies recruiting now, 382 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 221 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 106 studies in Pain with a site in Netherlands, or all of them as a file.
02

Study summary

The study is to compare the efficacy of autologous platelet concentrate injections to corticosteroid injection in patients suffering from tennis elbow with respect to pain and function.

Read the detailed description

Patients with chronic plantar fasciitis will be allocated randomly to have a steroid injection or an autologous platelet concentrate injections. Data will be collected before the procedure, 4, 8, 12, 26 weeks and 1 year after the procedure. The main outcome measures of this study are pain and function measured with questionnaires.

03

Conditions studied

  • Pain

Keywords

  • Tennis Elbow
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient with chronic epicondylitis lateralis who do not react to conservative treatment and therefore are send to the orthopedic surgeon

Exclusion criteria

Exclusion Criteria:

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
106 participants (actual)

Study arms

  • Experimental
    1

    PRP injection

    Biological: PRP Injection

  • Active comparator
    2

    Corticosteroid Injection

    Biological: Corticosteroid Injection

Interventions

  • BiologicalPRP Injection

    PRP Injection

  • BiologicalCorticosteroid Injection

    Corticosteroid Injection

06

What researchers measure

Primary outcomes

  1. Visual Analog Score - Pain

    Time frame: 4months,12 months,24months & 52 months

Secondary outcomes

  1. DASH

    Time frame: 4months,12months,24months & 52 months

  2. Complications

    Time frame: Anytime

07

Study locations

1 site
  • Elisabeth ziekenhuis
    Tilburg, Netherlands
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Aug 2007, a primary completion of Jan 2008 and a completion of Jan 2009. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 22, 2008
First posted
Sep 23, 2008
Start
Aug 2007
Primary completionActual
Jan 2008
CompletionActual
Jan 2009
Last update
May 19, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 19, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00757289
Lead sponsor
Zimmer Biomet
Responsible party
Sponsor
First posted
Sep 23, 2008
Start date
Aug 2007
Primary completion
Jan 2008
Completion
Jan 2009
Last update
May 19, 2017

Study contacts

Taco Gosens, MD
principal investigator · Elisabeth ziekenhuis

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Platelet rich plasma

Start the discussion